Calithera Biosciences, Inc.
Crystal forms of glutaminase inhibitors

Last updated:

Abstract:

The invention relates to crystalline salts of a compound having the structure of formula (I), methods for their preparation, and related pharmaceutical compositions comprising the crystalline salt. The invention further relates to methods of treating or preventing cancer or an immunological or neurological disease comprising administering a crystalline salt of the invention.

Status:
Grant
Type:

Utility

Filling date:

7 Jun 2019

Issue date:

9 Jun 2020